Novel genetic tools for diaminopimelic acid selection in virulence studies of Yersinia pestis

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Bland, David M ^a,b   Eisele, Nicholas A ^a,b   Keleher, Lauren L ^a   Anderson, Paul E ^a   Anderson, Deborah M ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; DIAMINOPIMELIC ACID; PROTEIN DAPA; UNCLASSIFIED DRUG; FLUORESCENT PROTEIN 583; PHOTOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUXOTROPHIC MUTANT; BACTERIAL CELL WALL; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; HOST PATHOGEN INTERACTION; MALE; MOUSE; NONHUMAN; OPERON; PHENOTYPE; PROMOTER REGION; REPLICON; SEPTICEMIA; YERSINIA PESTIS; ANIMAL; BACTERIAL GENE; BAGG ALBINO MOUSE; C57BL MOUSE; DISEASE MODEL; EXTRACELLULAR SPACE; FLUORESCENCE; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETIC COMPLEMENTATION; GENETIC PROCEDURES; GENETIC SELECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTRACELLULAR SPACE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PLAGUE; PLASMID; VIRULENCE;

BACTERIA (MICROORGANISMS); YERSINIA PESTIS; YERSINIA PESTIS KIM;

ANIMALS; DIAMINOPIMELIC ACID; DISEASE MODELS, ANIMAL; EXTRACELLULAR SPACE; FLUORESCENCE; GENE DOSAGE; GENES, BACTERIAL; GENETIC COMPLEMENTATION TEST; GENETIC TECHNIQUES; HUMANS; INTRACELLULAR SPACE; LUMINESCENT PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUTAGENESIS, INSERTIONAL; OPERON; PLAGUE; PLASMIDS; PROMOTER REGIONS, GENETIC; SELECTION, GENETIC; VIRULENCE; YERSINIA PESTIS;

EID: 79952299428     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017352     Document Type: Article

References (36)

1. Pollitzer R, (1954) Plague. Geneva, Switzerland World Health Organization.
2. Chain P, Carniel E, Larimer F, Lamerdin J, Stoutland P, et al. (2004) Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci 101: 13826-13831.
3. Lorange E, Race B, Sebbane F, Hinnebusch B, (2005) Poor vector competence of fleas and the evolution of hypervirulence in Yersinia pestis. J Infect Dis 191: 1907-1912.
4. Achtman M, Morelli G, Zhu P, Wirth T, Diehl I, et al. (2004) Microevolution and history of the plague bacillus, Yersinia pestis. Proc Natl Acad Sci 101: 17837-17842.
5. Auerbach R, Tuanyok A, Probert W, Kenefic L, Vogler A, et al. (2007) Yersinia pestis evolution on a small timescale: comparison of whole genome sequences from North America. PLoS One 2: e770.
6. Galimand M, Guiyoule A, Gerbaud G, Rasoamanana B, Chanteau S, et al. (1997) Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. New Eng J Med 337: 677-680.
7. Guiyoule A, Gerbaud G, Buchrieser C, Galimand M, Rahalison L, et al. (2001) Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis. Emerg Inf Dis 7: 43-48.
8. Welch T, Fricke W, McDermott P, White D, Rosso M, et al. (2007) Multiple antimicrobial resistance in plague: An emerging public health risk. PLoS One 2: 1-6.
9. Hutton C, Southwood T, Turner J, (2003) Inhibitors of lysine biosynthesis as antibacterial agents. Mini Rev Med Chem 3: 115-127.
10. Curtiss RR, Nakayama K, Kelly S, (1989) Recombinant avirulent Salmonella vaccine strains with stable maintenance and high level expression of cloned genes in vivo. Immumol Invest 18: 583-596.
11. Galan J, Nakayama K, Curtiss R III, (1990) Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 94: 29-35.
12. Bukhari A, Taylor A, (1971) Genetic analysis of diaminopimelic acid- and lysine-tequiring mutants of Escherichia coli. J Bacteriol 105: 844-854.
13. Rediers H, Bonnecarrere V, Rainey P, Hamonts H, Vanderleyden J, et al. (2003) Development and Application of a dapB-Based In Vivo Expression Technology System To Study Colonization of Rice by the Endophytic Nitrogen-Fixing Bacterium Pseudomonas stutzeri A15. App Env Microbiol 69: 6864-6874.
14. Norris M, Kang Y, Lu D, Wilcox B, Hoang T, (2009) Glyphosate resistance as a novel select-agent-compliant, non-antibiotic-selectable marker in chromosomal, mutagenesis of the essential genes asd and dapB of Burkholderia pseudomallei. App Env Microbiol 75: 6062-6075.
15. Parkhill J, Wren B, Thomson N, Titball R, Holden M, et al. (2001) Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413: 523-527.
16. Bouvier J, Pugsley A, Stragier P, (1991) A gene for a new lipoprotein in the dapA-purC interval of the Escherichia coli chromosome. J Bacteriol 173: 5523-5531.
17. Surgalla M, Beesley E, (1969) Congo red-agar plating medium for detecting pigmentation in Pasteurella pestis. App Microbiol 18: 834-837.
18. Brubaker R, Beesley E, Surgalla M, (1965) Pasteurella pestis: Role of Pesticin I and iron in experimental plague. Science 149: 422-424.
19. Hanahan D, (1985) DNA Cloning: A practical approach. In: Glover D, editors. IRL Press.
20. Yanisch-Perron C, Vieira J, Messing J, (1985) Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33: 103-119.
21. Simon R, Priefer U, Puhler A, (1983) A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Biotechnology 1.
22. Donnenberg M, Kaper J, (1991) Construction of an eae deletion mutant of Enteropathogenic Escherichia coli by using a positive selection suicide vector. Infect Immun 59: 4310-4317.
23. Choi K, Gaynor J, White K, Lopez C, Bosio C, et al. (2005) A Tn7-based broad-range bacterial cloning and expression system. Nat Methods 2: 443-448.
24. Richaud F, Richaud C, Ratet P, Patte J, (1986) Chromosomal location and nucleotide sequence of the Escherichia coli dapA gene. J Bacteriol 166: 297-300.
25. DeBord K, Anderson D, Marketon M, Overheim K, DePaolo R, et al. (2006) Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect Immun 74: 4910-4914.
26. Overheim K, DePaolo R, DeBord K, Morrin E, Anderson D, et al. (2005) LcrV plague vaccine with altered immunomodulatory properties. Infect Immun 73: 5152-5159.
27. Reed L, Muench H, (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27: 493-497.
28. Logsdon L, Mecsas J, (2003) Requirement of the Yersinia pseudotuberculosis Effectors YopH and YopE in Colonization and Persistence in Intestinal and Lymph Tissues. Infect Immun 71: 4595-4607.
29. Eisele N, Anderson D, (2009) Dual-function antibodies to Yersinia pestis LcrV required for pulmonary clearance of plague. Clin Vacc Immunol 16: 1720-1727.
30. Team RDC (2008) R: A language and environment for statistical computing. Computing RFfS, eds.
31. Peto R, Peto J, (1972) Asymptotically Efficient Rank Invariant Test Procedures. J Royal Stat Soc 135: 185-207.
32. Peters J, Craig N, (2001) Tn7: smarter than we thought. Nat Rev Mol Cell Biol 2: 806-814.
33. Anderson G, Leary S, Williamson E, Titball R, Welkos S, et al. (1996) Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule positive and negative strains of Yersinia pestis. Infect Immun 64: 4580-4585.
34. Lee-Lewis H, Anderson D, (2010) Absence of inflammation and pneumonia during infection with non-pigmented Yersinia pestis reveals new role for the pgm locus in pathogenesis. Infect Immun 78: 220-230.
35. Parra F, Britton P, Castle C, Jones-Mortimer M, Kornberg H, (1983) Two Separate Genes Involved in Sulphate Transport in Escherichia coli K12. J Gen Microbiol 129: 357-358.
36. Rückert C, Koch D, Rey D, Albersmeier A, Mormann S, et al. (2005) Functional genomics and expression analysis of the Corynebacterium glutamicum fpr2-cysIXHDNYZ gene cluster involved in assimilatory sulphate reduction. BMC Genomics 6: 121-138.